16 December 2019
The recent tragedy of White Island in New Zealand is a challenging situation for all involved. The surgical and trauma teams in many hospitals across New Zealand and Australia have put in heroic efforts and hours to support these patients, many still in a critical condition.
PolyNovo has supplied NovoSorb BTM to three hospitals in New Zealand and two Australian Hospitals with the BTM providing the best opportunity for dermal repair.
There are further surgeries scheduled for the week ahead and our team will continue to work closely with the hospital teams. The surgical and nursing teams have established clinical expertise in the use of NovoSorb BTM ensuring the best clinical outcomes for these patients. We expect to supply more product in the coming weeks.
Following the tragedy of the Bali Bombings, it became clear that there existed an urgent need for a dermal scaffold not compromised by the susceptibility to infection that characterises biologic, animal-based products. NovoSorb BTM mitigates some of the serious challenges inherent in treating mass trauma and burns. PolyNovo we have a mission to assist in the improvement of patients lives and their clinical outcomes.
PolyNovo’s CEO, Mr Paul Brennan said, “This is a terrible tragedy however in these circumstances you see the beauty of humankind’s capacity to care and support each other. We are humbled to work with surgical teams on both sides of the Tasman to support these people in a desperate time of need.”
Read the full media release here: ASX-Announcement-NZ-Tragedy-PNV-response-
Chief Executive Officer
Mobile +61 427 662 317
Mobile +61 414 383 593
NovoSorb is a novel range of bio-resorbable polymers that can be produced in many formats including, film, fibre, foam, and coatings. NovoSorb’s unique properties provide excellent biocompatibility, control over physical properties, and programmable bio-resorption profile. NovoSorb BTM is a dermal scaffold for the regeneration of the dermis when lost through extensive surgery or burn.
PolyNovo is an Australian based medical device company that designs, develops and manufactures dermal regeneration solutions (NovoSorb BTM) using its patented NovoSorb biodegradable polymer technology. Our development program covers Breast Sling, Hernia, and Orthopaedic applications. For further information and market presentations see www.polynovo.com.au